| Trade Names: | |
| Synonyms: | |
| Status: | Approved (2018) |
| Entry Type: | Unknown |
| Molecule Category: | UNKNOWN |
| UNII: | OKZ8S5CF14 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| None | Supplement | FDA |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Cholestasis | 4 | D002779 | ClinicalTrials |
| Carcinoma | 3 | D002277 | ClinicalTrials |
| Arthritis, Rheumatoid | 3 | D001172 | ClinicalTrials |
| Leukemia, Myeloid, Acute | 2 | D015470 | ClinicalTrials |
| Liver Diseases | 2 | D008107 | ClinicalTrials |
| Esophageal Atresia | 2 | D004933 | ClinicalTrials |
| Hepatitis | 2 | D006505 | ClinicalTrials |
| Retinopathy of Prematurity | 2 | D012178 | ClinicalTrials |
| Tachycardia, Ventricular | 1 | D017180 | ClinicalTrials |
| Death, Sudden, Cardiac | 1 | D016757 | ClinicalTrials |
Adverse Reactions
System Organ Classification (SOC)
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4297535 |
| FDA SRS | OKZ8S5CF14 |
CONTENTS